- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01695278
A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community (C4C)
19 novembre 2014 mis à jour par: Mercedes Carnethon, Northwestern University
Coaching for Control: A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community
Diabetes poses a substantial burden to racial/ethnic minorities and in populations with limited access to healthcare.
However, there is a shortage of healthcare providers available to help patients adopt the lifestyle changes required for diabetes control.
The goal of the present study is to evaluate the feasibility and effectiveness of a diabetes self-care intervention delivered by medical students to patients with poorly controlled diabetes.
Training medical students to use proven communication techniques to help patients identify and overcome barriers to adopting lifestyle changes in diabetes is a novel but plausible strategy.
The investigators anticipate that findings from our pilot study will be used to develop a larger study to definitively test the program's effectiveness.
A long-term benefit of our program is that future healthcare providers are practicing the skills needed to promote positive lifestyle changes and provide care for chronic conditions in diverse communities.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Diabetes and its complications pose a substantial physical, psychological and financial burden on the large number of racial/ethnic minorities and other socioeconomically deprived persons with diabetes.
However, self-management goals are often not met in racial/ethnic minorities and in populations with fewer socioeconomic resources.
In response, our research team has developed a novel "health coaching" intervention to promote diabetes self-management in the community.
Health coaching is based on Control Systems Theory and helps patients to: 1) identify problems in self-care behaviors; 2) create dynamic plans for correcting these issues; and, 3) learn to navigate the complexities of everyday life and to achieve clinically and personally desirable outcomes.
The primary innovation of the present project is that first-year medical students are trained to serve as the health coaches, and are participating in the study Coaching for Control (STU00069506).
The objective of our pilot study is to test whether 20 patients from five Northwestern Medicine primary care practice groups (two in the Austin community, two at Northwestern Memorial Hospital and one at Norwegian American Hospital) enrolled in the "Coaching for Control" intervention experience favorable changes in clinical and behavioral outcomes after 16 weeks as compared with an equal number of patients from those same clinics who are not enrolled in the program.
We will use a non-randomized trial design to carry out the following aims: 1. Determine whether patients with diabetes who participate in the "Coaching for Control" behavioral intervention program (i.e., the intervention arm) have lower hemoglobin A1c (HbA1c) after four months than patients who do not participate in the program (i.e., the control arm).
2. Determine whether diabetes patients in the intervention arm report higher task-related self-efficacy for initiating and maintaining recommended diabetes self-care behaviors than participants in the control arm.
We hypothesize that participants in the intervention arm will have more favorable HbA1c and report higher self-efficacy for diabetes self-care behaviors than participants in the control arm.
Secondary objectives are to test whether these changes persist 8 months after the program ends and to test whether we observe changes in additional clinical measures such as blood pressure, waist circumference, and in self-reported health behaviors such as medication adherence, self-care behaviors, physical activity and diet.
Process evaluations through focus groups and interviews with participants will allow us to refine our intervention.
The translational aspects of our proposal include the application of a proven intervention to promote diabetes self-care in a community setting that includes adults at high risk for diabetes complications.
Findings from the present pilot study will be used to justify expansion of the study to a larger group of community members so that we can carry out a larger randomized trial of efficacy.
Type d'étude
Interventionnel
Inscription (Réel)
16
Phase
- Phase 3
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Illinois
-
Chicago, Illinois, États-Unis, 60611
- Northwestern University
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- age > 18 years old,
- diagnosis of diabetes
- ability to read and understand English,
- access to a personal telephone,
- intent to remain in the medical practice group for at least 1 year,
- intention to remain in the Chicago, IL area or surrounding suburbs for 1 year.
- Ability to read and understand the informed consent.
Exclusion Criteria:
- primary diagnosis of gestational diabetes or type 1 diabetes
- severe mental impairment,
- primary preferred language other than English
- severe comorbidity with a life expectancy of < 1 year
- currently enrolled in another counseling-based diabetes intervention program
- prior participation in the Coaching for Control intervention development in 2012
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Non randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur actif: Standard Care
Participants will receive standard care from physicians for monitoring and treating their diabetes.
They are placed on a wait list to receive the intervention.
|
Weekly telephone counseling intervention for 16 weeks, used to identify and overcome barriers to diabetes control and set goals for positive behavioral changes supplemented by monthly group classes on skill development.
|
Expérimental: Telephone Counseling
Weekly telephone counseling intervention for 16 weeks, used to identify and overcome barriers to diabetes control and set goals for positive behavioral changes supplemented by monthly group classes on skill development.
|
Weekly telephone counseling intervention for 16 weeks, used to identify and overcome barriers to diabetes control and set goals for positive behavioral changes supplemented by monthly group classes on skill development.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change in hemoglobin A1c
Délai: 16 weeks
|
Changes in hemoglobin A1c between baseline and the end of follow-up will be compared between participants in the intervention arm vs. the control arm.
|
16 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Task related self-efficacy for initiating and maintaining diabetes self-management
Délai: 16 weeks
|
Determine whether diabetes patients in the intervention arm report higher task-related self-efficacy for initiating and maintaining recommended diabetes self-care behaviors than participants in the wait list control arm.
|
16 weeks
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Diabetes self-management behaviors
Délai: 16 weeks
|
To describe differences in diabetes self-management behavior in participants in the intervention as compared with the wait list control arm
|
16 weeks
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Mercedes R Carnethon, PhD, Northwestern University
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 septembre 2012
Achèvement primaire (Réel)
1 janvier 2014
Achèvement de l'étude (Réel)
1 août 2014
Dates d'inscription aux études
Première soumission
24 septembre 2012
Première soumission répondant aux critères de contrôle qualité
26 septembre 2012
Première publication (Estimation)
27 septembre 2012
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
21 novembre 2014
Dernière mise à jour soumise répondant aux critères de contrôle qualité
19 novembre 2014
Dernière vérification
1 novembre 2014
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- STU00068025
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Diabète sucré, Type 2
-
Bnai Zion Medical CenterInconnue
-
Jiangsu HengRui Medicine Co., Ltd.Complété
-
Endogenex, Inc.Pas encore de recrutementDiabète sucré, Type 2 | Diabète | Diabète sucré de type 2 | Diabète de type 2 | Diabète de type 2
-
Jeil Pharmaceutical Co., Ltd.Pas encore de recrutementDiabète sucré de type 2Corée, République de
-
Nanjing First Hospital, Nanjing Medical UniversityRecrutement
-
Nanjing First Hospital, Nanjing Medical UniversityRecrutement
-
Xiangya Hospital of Central South UniversityRecrutement
-
Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; The Third Affiliated... et autres collaborateursRecrutement
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...ComplétéDiabète sucré de type 2Royaume-Uni
Essais cliniques sur Telephone Counseling
-
University of MelbourneBeyondblue (The National Depression Initiative)Complété
-
Matthew Bush, MDComplétéPerte d'audition | Troubles auditifsÉtats-Unis
-
Academisch Ziekenhuis MaastrichtRecrutementMaladies cardiovasculaires | Facteur de risque cardiovasculairePays-Bas
-
Fox Chase Cancer CenterNational Cancer Institute (NCI); Albert Einstein College of Medicine; Christiana... et autres collaborateursComplétéCancer du seinÉtats-Unis
-
American University of SharfahJordan Hospital; Sheikh Khalifa Medical CityInconnueObésité | Chirurgie bariatriqueJordan, Emirats Arabes Unis
-
Virginia Commonwealth UniversityNational Institute on Disability, Independent Living, and Rehabilitation...ComplétéLésion cérébrale traumatiqueÉtats-Unis
-
Ascension Genesys HospitalUniversity of Pennsylvania; Robert Wood Johnson FoundationComplété
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)ComplétéTrichotillomanieÉtats-Unis
-
FHI 360University of North Carolina; Ministry of Health, Madagascar; National Reference...Complété
-
Makerere UniversityWellcome Trust; Infectious Diseases Institute; Training Health research into...InconnueVIH | Consommation d'alcoolOuganda